NASDAQ
NeuBase Therapeutics, Inc. (NBSE) has a total debt of $6.00M as of Friday, September 30, 2022. Total debt represents the sum of a company's short-term and long-term borrowings, indicating its overall leverage and financial obligations.
No price data available for this timeframe.